References
- Chelemer SB, Prato BS, Cox PM, Jr, O'Connor GT, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg. 2002; 73: 138–42
- Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005; 27: 592–8
- Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002; 74: 1180–6
- Henry, DA, Moxey, AJ, Carless, PA, O'Connell, D, McClelland, B, Henderson, KM, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 1999: CD001886.
- Carless, PA, Henry, DA, Moxey, AJ, O'Connell, DL, Fergusson, DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2003: CD001888.
- Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion. 1999; 39: 1070–7
- Cheng DC, Bainbridge D, Martin JE, Novick RJ. Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. 2005; 102: 188–203
- Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, et al. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial. J Thorac Cardiovasc Surg. 2005; 130: 20–8